查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386587

核酸检测市场报告：2030 年趋势、预测与竞争分析

Nucleic Acid Testing Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

核酸检测趋势与预测

预计到2030年，全球核酸检测市场将达到67亿美元，2024年至2030年年复合成长率为11.2%。该市场的主要驱动力是对准确和快速诊断测试的需求不断增长，对血库和输血中心核酸检测套组的需求不断增长，以及癌症、遗传疾病和感染疾病的增加。全球核酸检测市场前景广阔，医院/诊所、病理实验室、学术/研究所市场蕴藏商机。

核酸检测市场洞察

Lucintel 预测，由于大量使用核酸检测套组进行基因分型和亚型分型以帮助确定病毒量，感染疾病将继续成为最大的细分市场。

由于人口中感染疾病的盛行率不断上升以及政府对核酸检测研究和开发的大力支持，预计北美在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2. 哪些细分市场最有前景且成长潜力最大？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球核酸检测市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球核酸检测市场趋势（2018-2023）与预测（2024-2030）
  • 按产品类型分類的全球核酸检测市场
    • 聚合酶炼式反应
    • 连接酶炼式反应
    • 转录媒介增幅
    • 全基因组序列测定
    • 其他的
  • 按适应症分類的全球核酸检测市场
    • 感染疾病
    • 癌症
    • 刑事鑑定
    • 个人化医疗
    • 其他的
  • 按最终用途分類的全球核酸检测市场
    • 医院和诊所
    • 病理研究所
    • 学术/研究机构
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球核酸检测市场（按地区）
  • 北美核酸检测市场
  • 欧洲核酸检测市场
  • 亚太核酸检测市场
  • 其他区域核酸检测市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球核酸检测市场成长机会
    • 全球核酸检测市场成长机会（按适应症）
    • 按最终用途分類的全球核酸检测市场成长机会
    • 全球核酸检测市场按地区成长机会
  • 全球核酸检测市场新趋势
  • 战略分析
    • 新产品开发
    • 全球核酸检测市场产能扩张
    • 全球核酸检测市场的合併与收购
    • 认证和许可

第7章主要企业概况

  • F. Hoffmann-La Roche
  • Becton and Dickinson
  • Danaher
  • Abbott Laboratories
  • Illumina
  • Siemens Healthineers
  • bioMerieux
简介目录

Nucleic Acid Testing Trends and Forecast

The future of the global nucleic acid testing market looks promising with opportunities in the hospital & clinic, pathology laboratory, and academic & research organization markets. The global nucleic acid testing market is expected to reach an estimated $6.7 billion by 2030 with a CAGR of 11.2% from 2024 to 2030. The major drivers for this market are rising need for precise and quick diagnostic tests, increasing need for nucleic acid test kits from blood banks and transfusion centers, and escalating incidence of cancer, genetic disorders, and infectious diseases.

A more than 150-page report is developed to help in your business decisions.

Nucleic Acid Testing by Segment

The study includes a forecast for the global nucleic acid testing by product type, indication, end use, and region.

Nucleic Acid Testing Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Polymerase Chain Reaction
  • Ligase Chain Reaction
  • Transcription-Mediated Amplification
  • Whole Genome Sequencing
  • Others

Nucleic Acid Testing Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Infectious Disease
  • Cancer
  • Forensic Testing
  • Personalized Medicine
  • Others

Nucleic Acid Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Pathology Laboratories
  • Academic & Research Organization
  • Others

Nucleic Acid Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Nucleic Acid Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies nucleic acid testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nucleic acid testing companies profiled in this report include-

  • F. Hoffmann-La Roche
  • Becton and Dickinson
  • Danaher
  • Abbott Laboratories
  • Illumina
  • Siemens Healthineers
  • bioMerieux

Nucleic Acid Testing Market Insights

Lucintel forecasts that infectious disease will remain the largest segment due to considerable use of nucleic acid testing kit for genotype and subtype identification that aids in determining viral load.

North America is expected to witness highest growth over the forecast period due to increasing prevalence of infectious diseases among population and presence of strong government support for nucleic acid testing research and development in the region.

Features of the Global Nucleic Acid Testing Market

Market Size Estimates: Nucleic acid testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Nucleic acid testing market size by product type, indication, end use, and region in terms of value ($B).

Regional Analysis: Nucleic acid testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, indications, end uses, and regions for the nucleic acid testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nucleic acid testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the nucleic acid testing market size?

Answer: The global nucleic acid testing market is expected to reach an estimated $6.7 billion by 2030.

Q.2 What is the growth forecast for nucleic acid testing market?

Answer: The global nucleic acid testing market is expected to grow with a CAGR of 11.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the nucleic acid testing market?

Answer: The major drivers for this market are rising need for precise and quick diagnostic tests, increasing need for nucleic acid test kits from blood banks and transfusion centers, and escalating incidence of cancer, genetic disorders, and infectious diseases.

Q4. What are the major segments for nucleic acid testing market?

Answer: The future of the nucleic acid testing market looks promising with opportunities in the hospital & clinic, pathology laboratory, and academic & research organization markets.

Q5. Who are the key nucleic acid testing market companies?

Answer: Some of the key nucleic acid testing companies are as follows:

  • F. Hoffmann-La Roche
  • Becton and Dickinson
  • Danaher
  • Abbott Laboratories
  • Illumina
  • Siemens Healthineers
  • bioMerieux

Q6. Which nucleic acid testing market segment will be the largest in future?

Answer: Lucintel forecasts that infectious disease will remain the largest segment due to considerable use of nucleic acid testing kit for genotype and subtype identification that aids in determining viral load.

Q7. In nucleic acid testing market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to increasing prevalence of infectious diseases among population and presence of strong government support for nucleic acid testing research and development in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the nucleic acid testing market by product type (polymerase chain reaction, ligase chain reaction, transcription-mediated amplification, whole genome sequencing, and others), indication (infectious disease, cancer, forensic testing, personalized medicine, and others), end use (hospitals & clinics, pathology laboratories, academic & research organization, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Nucleic Acid Testing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Nucleic Acid Testing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Nucleic Acid Testing Market by Product Type
    • 3.3.1: Polymerase Chain Reaction
    • 3.3.2: Ligase Chain Reaction
    • 3.3.3: Transcription-mediated Amplification
    • 3.3.4: Whole Genome Sequencing
    • 3.3.5: Others
  • 3.4: Global Nucleic Acid Testing Market by Indication
    • 3.4.1: Infectious Disease
    • 3.4.2: Cancer
    • 3.4.3: Forensic Testing
    • 3.4.4: Personalized Medicine
    • 3.4.5: Others
  • 3.5: Global Nucleic Acid Testing Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Pathology Laboratories
    • 3.5.3: Academic & Research Organization
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Nucleic Acid Testing Market by Region
  • 4.2: North American Nucleic Acid Testing Market
    • 4.2.1: North American Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
    • 4.2.2: North American Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others
  • 4.3: European Nucleic Acid Testing Market
    • 4.3.1: European Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
    • 4.3.2: European Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others
  • 4.4: APAC Nucleic Acid Testing Market
    • 4.4.1: APAC Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
    • 4.4.2: APAC Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others
  • 4.5: ROW Nucleic Acid Testing Market
    • 4.5.1: ROW Nucleic Acid Testing Market by Indication: Infectious Disease, Cancer, Forensic Testing, Personalized Medicine, and Others
    • 4.5.2: ROW Nucleic Acid Testing Market by End Use: Hospitals & Clinics, Pathology Laboratories, Academic & Research Organization, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Nucleic Acid Testing Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Nucleic Acid Testing Market by Indication
    • 6.1.3: Growth Opportunities for the Global Nucleic Acid Testing Market by End Use
    • 6.1.4: Growth Opportunities for the Global Nucleic Acid Testing Market by Region
  • 6.2: Emerging Trends in the Global Nucleic Acid Testing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Nucleic Acid Testing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nucleic Acid Testing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: F. Hoffmann-La Roche
  • 7.2: Becton and Dickinson
  • 7.3: Danaher
  • 7.4: Abbott Laboratories
  • 7.5: Illumina
  • 7.6: Siemens Healthineers
  • 7.7: bioMerieux